Trials / Completed
CompletedNCT00956319
A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients
A Randomized, Open-Label, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Zolpidem Modified Release (MR) in Patients With Primary Insomnia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the efficacy and safety of zolpidem modified release (MR) tablet using estazolam (Eurodin) as a comparative drug in patients with primary insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zolpidem MR | oral |
| DRUG | Estazolam | oral |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-08-11
- Last updated
- 2011-10-06
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00956319. Inclusion in this directory is not an endorsement.